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89809-000 Chapecó, SC, Brazil
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The jaboticaba tree, Plinia trunciflora (O. Berg) Kausel, is popularly named “jabuticabeira” in Brazil and is used in folk medicine to
treat diabetes and chronic inflammation of the tonsils, but studies evaluating the central effects of this species are limited.This study
evaluated the antidepressant-like and antioxidant effects of P. trunciflora (PT) aqueous extract, in which five different anthocyanins
were identified. PT showed significant ferric-reduction power and DPPH radical scavenging activity in vitro and reduced lipid
peroxidation both in vitro and ex vivo. At the behavioural level, PT (400 and 800mg/kg, i.p.) dose-dependently reduced immobility
time in the tail suspension test in Swiss male mice. The identification of bioactive compounds accompanied by the in vitro and ex
vivo antioxidant activity of PT suggests that these activities might be related to the antidepressant-like activity of P. trunciflora.
1. Introduction
Depression is a common, serious, and recurrent chronic
affective disorder characterized by anhedonia, headache,
sleep disturbances, changes in sexual desire, and a loss of
energy [1]. This disease is among the five most prevalent in
the world and is expected to be the second leading cause
of disability in 2020 [2]. The monoaminergic hypothesis
of depression [3] does not provide a full understanding of
the progression, causes, and pharmacotherapy of depression.
New hypotheses have been postulated, and oxidative stress
has been suggested to be involved in the pathophysiology of
depression [4].
Oxidative stress is a condition in which an imbalance
between the production of free radicals and endogenous
antioxidant defenses occurs [5], culminating in decreased cell






) produced during respiratory chain may
generate the highly deleterious hydroxyl radical (∙OH) via
the Fenton reaction [6]. The overproduction of these species
is related to protein, DNA, and lipid oxidation [7] as well
as the inactivation of important antioxidant enzymes, such
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as catalase (CAT), superoxide dismutase (SOD), glutathione
peroxidase (GPx), and thioredoxin reductase (TrxR) [5].
The overproduction of ROS and oxidative stress have been
implicated in the pathophysiological processes related to
various diseases, including Alzheimer’s, Parkinson’s, anx-
iety, and depression [8–10]. In this sense, plants emerge
as potential alternatives for the treatment of oxidative
stress-related diseases, considering that they are important
sources of carotenoids, flavonoids, vitamins, and polyphe-
nols.
TheMyrtaceae family consists of 4,620 species distributed
in 140 genera whose occurrence has been described in
subtropical and tropical regions of the world, mainly Cen-
tral and South America and Australia [11]. The jaboticaba
tree, Plinia trunciflora (O. Berg) Kausel, a synonym of
Myrciaria trunciflora O. Berg, Eugenia cauliflora O. Berg,
and Myrciaria peruviana (Poir.) Mattos is popularly named
“jabuticabeira” in Brazil (source: http://www.tropicos.org/).
In folk medicine, species of Plinia have been used to treat
various diseases, such as diabetes and chronic inflammation
of the tonsils [12]. However, studies that evaluate the effects of
this species on the central nervous system (CNS) are scarce in
the literature. Therefore, the aim of this study was to evaluate
the antidepressant-like effect of P. trunciflora aqueous extract
in the tail suspension test. The identification of bioactive
compounds and the in vitro and ex vivo antioxidant effects
of P. trunciflora were investigated in order to establish if the
antidepressant-like effect of this plant could be related to
these properties.
2. Materials and Methods
2.1. Plant Material. The whole fruits of Plinia trunciflora
were collected in Alpestre (RS, Brazil) (27∘10󸀠56.82󸀠󸀠S and
53∘7󸀠19.55󸀠󸀠O), in September, and taxonomically identified by
Marcos Eduardo Guerra Sobral (botanical), where a voucher
has been deposited in the university herbarium (number
3302).
2.2. Preparation of Aqueous Extract of P. trunciflora (PT).
The aqueous extracts of whole fruits were prepared based
on the methodology described by Kuskoski et al. [13]. The
whole fruit (100 g) of P. trunciflora was mixed with 200mL
of distilled water and acidified with concentrated HCl until
pH 1.5. After trituration for 1 min, the solution was cooled to
4∘C over 12 h to extract the anthocyanins. The solution was
then centrifuged, and the supernatant was frozen and further
lyophilized. Prior to the in vitro and ex vivo experiments, the
lyophilized material was dissolved in ultrapure water (Milli-
Q) at the desired concentrations or doses.
2.3. Total Phenolic Compounds (TPC). The total phenolic
compounds (TPC) in the PT were determined according to
the method described by Singleton and Rossi [14], which
is based on the reduction of the phosphowolframate phos-
phomolybdate complex by phenolics to a blue product that
is measured at 750 nm. The results are expressed as gallic
acid equivalents (mg gallic acid equivalents/100 g fresh fruit),
and the values are presented as the means of triplicate analy-
sis.
2.4. Total Monomeric Anthocyanins (TMA). The total mon-
omeric anthocyanin (TMA) content was determined using
the pH differential method [15]. The anthocyanin con-
tent was calculated using the molar absorptivity (𝜀) and
molecular weights (MW) of cyanidin 3-O-glucoside (𝜀 =
26,900 L/mol⋅cm; MW = 449.2 g/mol). The results are ex-
pressed as mg of cyanidin 3-O-glucoside equivalents/100 g
fresh fruit.
2.5. Identification and Quantification of Anthocyanins in PT
2.5.1. Chemical, Apparatus, and General Procedures. All
chemicals were of analytical grade. Acetonitrile and formic
acid were purchased from Merck (Darmstadt, Germany).
Cyanidin chloride, malvidin chloride, cyanidin 3-O-gluco-
side chloride, malvidin 3-O-glucoside chloride, and delphini-
din 3-O-glucoside chloride were acquired from ChromaDex.
High performance liquid chromatography (HPLC-DAD)was
performed with a Shimadzu Prominence Auto Sampler (SIL-
20A) HPLC system (Shimadzu, Kyoto, Japan) equipped with
Shimadzu LC-20AT reciprocating pumps connected to a
DGU 20A5 degasser with a CBM 20A integrator, SPD-M20A
diode array detector, and LC solution 1.22 SP1 software.
2.5.2. Quantification of Compounds by HPLC-DAD. Reverse
phase chromatographic analyses were carried out under
gradient conditions using a C18 column (4.6mm × 150mm)
packed with 5 𝜇m diameter particles; the mobile phase was
water containing 1% formic acid (A) and acetonitrile (B),
and the composition gradient was 13% of B until 10min
and changed to obtain 20%, 30%, 50%, 60%, 70%, 20%, and
10% B at 20, 30, 40, 50, 60, 70, and 80min, respectively
[16]. The P. trunciflora aqueous extract and mobile phase
were filtered through a 0.45 𝜇m membrane filter (Millipore)
and then degassed in an ultrasonic bath prior to use; the
aqueous extractwas analyzed at a concentration of 20mg/mL.
The flow rate was 0.5mL/min, the injection volume was
20𝜇L, and the wavelength was 520 nm. Stock solutions of
standards references were prepared in the HPLC mobile
phase at a concentration range of 0.030 to 0.250mg/mL.
The chromatography peaks were confirmed by comparing
their retention times with those of the reference standards
and DAD spectra (300 to 700 nm). All chromatography
operations were carried out at ambient temperature and in
triplicate [17].
2.6. Antioxidant Activity In Vitro
2.6.1. Determination of Ferric Reducing Antioxidant Power
(FRAP). The FRAP assay was based on Benzie and Strain
[18], by measuring the absorbance of the complex formed
between Fe2+ and Ferric-2,4,6-tripyridyl-s-triazine (TPTZ)
at 593 nm after incubation (37∘C/15min) with PT (10–
160 𝜇g/mL). The increase in the absorbance was compared
to that induced by ascorbic acid (standard), and the results
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are expressed as the means of the absorbance of triplicate
experiments (𝑛 = 3).
2.6.2. 1,1-Diphenyl-2-2-picrylhydrazyl Radical Scavenging
Assay. The antiradical powers of the different concentrations
of PT (10–160 𝜇g/mL) and standard were determined by
measuring the decrease in the DPPH absorbance after 24 h
in the dark compared to a blank [19]. The same procedure
was followed for the ascorbic acid standard.This analysis was
carried out in triplicate (𝑛 = 3), and the results are expressed
as the means of % inhibition of the DPPH radical, which
was calculated as follows: % inhibition = [(Abs control –
Abs sample)/Abs control] × 100. The concentration of PT
that could scavenge 50% of the DPPH radical (IC
50
) was
calculated via a nonlinear regression analysis using the
GraphPad Prism Program version 6.0.
2.6.3. Protection against Lipid Peroxidation. A low-speed
supernatant (20min at 2000×g) of brain homogenates
(50mMTris-HCl, pH 7.5, 1 : 9; w/v) was preincubated at 37∘C







PT (10–160 𝜇g/mL), and Tris-HCl 50mM. Subsequently, the
amount of thiobarbituric acid-reactive substances (TBARS)
was determined [20].The inhibitory concentration 50 (IC
50
),
which represents the concentration of PT that inhibits 50% of
lipid peroxidation, was determined via a nonlinear regression
analysis using the GraphPad Prism Program version 6.0.
2.7. In Vivo Studies
2.7.1. Animals. 80 two-month-old male Swiss mice (30–40 g)
were obtained from the Bioterism Center of Unochapecó.
Seven mice were housed per cage (30 × 19 × 13 cm) and
maintained in our own animal facility under controlled
environmental conditions (22 ± 1∘C, 12 hr light/dark cycle,
free access to food (Nuvilab CR1) and water). All procedures
were carried out in accordance with institutional policies on
the handling of experimental animals (approved by the ethics
committee, process 001/2012).
2.7.2. Drugs. Fluoxetine was used as commercial Daforin
(Laboratório EMS, SP, Brazil). All drugs were dissolved in
saline (NaCl 0.9%). The drugs and saline were administered
intraperitoneally (i.p.) or orally (p.o.) at a constant volume of
0.1mL/10 g body weight.
2.7.3. Tail Suspension Test (TST). The TST was used as
described by Steru et al. [21]. Mice (𝑛 = 7–10) were orally
treated with vehicle (0.9% saline; w/v) or PT (200, 400 or
800mg/kg). An additional group was treated with fluoxetine
(32mg/kg, i.p.). None of the selected doses modified locomo-
tion in the open field test (data not shown). The mice were
submitted to the TST for 30 or 60min (for i.p. and p.o. treated
groups, resp.) after treatments. After the TST, the animals
were euthanized, and their brains were removed immediately
in order to assess the oxidative stress parameter ex vivo. The
ex vivo analyses were performed in the PT 800mg/kg group
because the behavioral effects of this dose were comparable
to those of fluoxetine.
2.8. Antioxidant Activity Ex Vivo
2.8.1. Antioxidant Enzymes. The antioxidant activity was
assessed ex vivo using homogenized mouse brains in 7
volumes of 50mM Tris buffer (pH 7.4). The homogenate was
centrifuged at 3000×g and 4∘C for 10min to yield a low-speed
supernatant for which all parameters were evaluated. The
SOD, CAT, and GPx activity were determined according to
Misra and Fridovich [22], Aebi [23], and Paglia and Valentine
[24], respectively. The TrxR activity was determined using
5,5󸀠-dithiobis (2-nitrobenzoic acid) (DTNB) and NADPH
[25]. Gold (III) chloride trihydrate (500 nM) was used to
inhibit the thioredoxin reductase activity [26] and determine
the nonthioredoxin reductase DTNB reduction, which was
subtracted from the total DTNB reduction in order to obtain
the thioredoxin reductase activity. The amount of reduced
DTNBwas calculated using an absorption coefficient of 13.6×
103/mol/cm.
2.8.2. Nonprotein Thiol Groups. The low-speed supernatant
fraction was mixed with 10% trichloroacetic acid (1 : 1 v/v),
followed by the centrifugation and neutralization of the
supernatant (to pH 7.5) with 1M Tris. The nonprotein thiol
groups were immediately determined using a standard curve
of cysteine [27].
2.8.3. Protein Quantification. The protein content was mea-
sured using bovine serum albumin as a standard [28].
2.8.4. Lipid Peroxidation. After the addition of 7.2mM
butylated hydroxytoluene to prevent further oxidation, the
supernatant was used to determine the amount of reactive
thiobarbituric acid [20]. The samples were extracted with n-
butanol, and the reaction product was determined at 535 nm
using a standard curve of 1,1,3,3-tetraethoxypropane.
2.9. Statistical Analysis. The results (cumulative counts for
spontaneous locomotion, time in seconds for immobility, and
antioxidant activity in vitro and ex vivo) are expressed as the
mean ± S.E.M. Comparisons between the groups were made
by one-way ANOVA followed by Tukey’s post hoc test. The
differences between the data were analyzed using Student’s
𝑡-test to assess the antioxidant activity in vitro (different
concentrations of PT × different concentrations of ascorbic
acid). Results with 𝑝 < 0.05 were considered significant. The
regression analyses were made using Statistica 7.0 software
system (Statsoft Inc., 2001).
3. Results
The content of antioxidant compounds, such as total phe-
nolics and anthocyanins, was quantified. The total phenolic
compounds in the aqueous extract of P. trunciflora were
1201.67 ± 33.29mg GAE/100 g, while the anthocyanins
















































































Figure 1: Representative high performance liquid chromatography profiles of the standards cyanidin chloride (a), malvidin chloride (b),
delphinidin 3-O-glucoside chloride (c), cyaniding 3-O-glucoside chloride (d), malvidin 3-O-glucoside chloride (e), and PT (f).
content was 175.33 ± 11.80mg cyanidin 3-O-glucoside equiv-
alents/100 g.
The HPLC fingerprinting of the P. trunciflora aqueous
extract (Figure 1) revealed the presence of anthocyanins.
We identified cyanidin (Rt = 6.41min; peak 1), malvidin
(Rt = 9.73min; peak 2), delphinidin 3-O-glucoside (Rt =
11.94min; peak 3), cyanidin 3-O-glucoside (Rt = 15.08; peak
4), and malvidin 3-O-glucoside (Rt = 20.57min; peak 5).
The composition of anthocyanins (mg/g) in the P. trunciflora
aqueous extract was cyanidin (16.2 ± 0.01), malvidin (3.5 ±
0.02), delphinidin 3-O-glycoside (24.1 ± 0.03), cyanidin 3-O-
glycoside (27.6 ± 0.03), and malvidin 3-O-glycoside (17.1 ±
0.02).
A one-way ANOVA revealed that PT showed signifi-
cant reducing power beyond a concentration of 10𝜇g/mL
(Figure 2(a)). However, the ferric reducing power of ascorbic















































Figure 2: Ferric reducing antioxidant power (FRAP (a)) andDPPHradical scavenger activity (b) of PT.The results are expressed as the mean ±
S.E.M. 𝑛 = 3. (a) ∗Different from ascorbic acid solution at the same concentration. ∗𝑝 < 0.05; Student’s 𝑡-test. Different symbols represent
different results within the PT group (𝑝 < 0.01, ANOVA/Tukey). (b) ∗Different from DPPH radical scavenger activity of ascorbic acid
solution at the same concentration. ∗𝑝 < 0.001, Student’s 𝑡-test. Different symbols represent different results within the PT group (𝑝 < 0.05,
ANOVA/Tukey).
acid was higher than that shown by PT in all concentrations
evaluated, as evident from Student’s 𝑡 test. Figure 2(b) shows
the DPPH radical scavenging antioxidant activity. Although
the DPPH radical scavenging ability of PT was lower than
that of the ascorbic acid solution, it was remarkable at all
evaluated concentrations. The calculated IC
50
value for PT
was 42.2 𝜇g/mL, compared to a value of 0.04𝜇g/mL for
ascorbic acid. At 10 and 20 𝜇g/mL, PT inhibited between
11 and 14% of DPPH; at 40 𝜇g/mL, the inhibition increased
to 50% and exceeded 80% at concentrations of 80 and
160 𝜇g/mL.
The extract inhibited the lipid peroxidation in a
homogenate of mouse brain at all concentrations (Figure 3).
At 10 𝜇g/mL, PT inhibited approximately 20% of lipid
peroxidation, and the inhibition increased to 40% at 20 and
40 𝜇g/mL and reached 60% at concentrations of 80 and
160 𝜇g/mL.The calculated IC
50
value for PT was 70.4𝜇g/mL.
The results in Figure 4 show the effects of PT (200, 400,
and 800mg/kg, p.o.) and fluoxetine (32mg/kg, i.p.) during
the tail suspension test in mice. PT significantly reduced
the immobility time in the TST (400 and 800mg/kg, p.o.,
𝐹
4,40
= 48, 𝑝 < 0.0001). Fluoxetine significantly reduced the
immobility time in the TST. The PT (800mg/kg, p.o.) was
compared with fluoxetine. The spontaneous locomotion of
groups treated with PT did not differ from the controls (data
not shown).
Figure 5 presents the effect of PT (800mg/kg, p.o.) and
fluoxetine (32mg/kg, i.p.) administration on the antioxidant
enzyme activities in the homogenate of mouse brains. PT
and fluoxetine did not result in significant changes in the





























Figure 3: Inhibition of Fenton reaction-induced lipid peroxidation
of PT. The results are expressed as the means ± S.E.M. 𝑛 =
5. ∗Different symbols represent different results within the PT group
(𝑝 < 0.05, ANOVA/Tukey).
activities compared to the controls; fluoxetine significantly
increased the CAT (Figure 5(d)) activity compared to the
controls.
Figure 6 shows the effect of PT (800mg/kg, p.o.) and flu-
oxetine (32mg/kg, i.p.) on the lipid peroxidation and level of
nonprotein thiol groups (NPSH) in the homogenate ofmouse
brains. Both the PT extract and the fluoxetine attenuated lipid
peroxidation (Figure 6(a)). The levels of nonprotein thiol in
the PT extract and fluoxetine (Figure 6(b)) groups did not
differ from that of the control.
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Figure 4: Effects of PT (200, 400, and 800mg/kg, p.o.) and fluoxe-
tine (32mg/kg, i.p.) in the TST. Each column represents the mean ±
S.E.M. 𝑛 = 7–10. ∗𝑝 < 0.0001 × saline. ANOVA/ Tukey.
4. Discussion
Depression has been associated with lowered concentra-
tions of several endogenous antioxidant compounds, such as
coenzyme Q10, vitamins C and E, or antioxidant enzymes,
such as GPx [29]. In addition, ROS and RNS have been
shown to modulate neurotransmitter systems involved in the
neurobiology of depression [30]. In this context, this study
intended to evaluate the antidepressant-like effect of a P.
trunciflora (PT) aqueous extract using the TST. Moreover,
considering that jaboticaba species are rich in flavonoids and
related polyphenols [31], the antioxidant effects of PT were
evaluated by in vitro and ex vivo assays.
Our results showed for the first time that oral PT (400
and 800mg/kg) had antidepressant-like activity in the TST.
This effect was dose related (𝑟 = −0.84, 𝑝 < 0.001,
Pearson correlation analysis). Furthermore, the effect of PT
(800mg/kg) was comparable to that of the antidepressant flu-
oxetine (32mg/kg), a selective serotonin reuptake inhibitor.
To avoid false positives in the TST, our results showed that
PT treatment did not alter locomotor activity in the open field
test (Figure 1S, in Supplementary Material available online at
http://dx.doi.org/10.1155/2015/601503).
Although the mechanisms of the antidepressant-like
activity of PT remain unclear, the bioactive compounds
currently identified as well as their antioxidant properties
may be involved in this effect. Flavonoids, such as antho-
cyanins, stand out among the major classes of phenolic
compounds of plants [32].The cyanidin-3-O-glycoside (peak
4) was the dominant anthocyanin present in our extract.
Other anthocyanins, such as delphinidin 3-O-glucoside and
cyanidin- 3-O-glucoside, were also detected. Importantly, the
antioxidant effects of these compounds have been described
in the literature [33]. Data of linear regression revealed a
substantial contribution of TPC and TMA for the reducing
antioxidant power of PT assessed by FRAP method (𝑅 =
0.96 and 𝑅 = 0.97, 𝑝 = 0.00001, resp.; see Figures 2S-3S,
supplementary data). TPC and TMA also contributed to %
inhibition of DPPH and % inhibition of lipid peroxidation
(𝑅 = 0.83 and 𝑅 = 0.93, resp.), as demonstrated
by nonlinear regression (see Figures 4S–7S, supplementary
data).
The FRAP assay measures the ability of an antioxidant
substance to donate one electron [18]. Because the antioxi-
dant activity of a substance correlates with its reducing prop-
erties, the reduction of the 2,4,6-tripyridyl-s-triazine-Fe(III)
complex due to PT indicates the presence of compounds that
can donate electrons, such as phenolic compounds. Accord-
ingly, the antioxidant properties of the Syzygium cumini fruit
skin may in part be due to the antioxidant vitamins, tannins,
phenolics, and anthocyanin compounds present in the fruit
[34].
The reducing power of PT was corroborated by the
DPPH radical scavenging assay, which also evaluates the
ability of antioxidants to transfer a single electron. This
affirmation is based on the fact that both the reducing and
the scavenging DPPH abilities of the extract were observed
in the entire evaluated concentration range (10–160𝜇g/mL).
Therefore, these results strongly suggest that the DPPH
radical scavenging capacity of PT is related to its reducing
properties, as evidenced in the FRAP assay. Conversely, PT










oxidation of GSH (data not shown).
Lipid peroxidation is an index of oxidative stress and
may result in damage to components of the cell membrane,
which may lead to calcium influx and cell death. Lipid
peroxidation is associated with several diseases, including
neurodegenerative disorders [35], and antioxidants may pro-
tect against lipid peroxidation by scavenging the free radicals
[36]. The in vitro results of the current study showed that
PT inhibited the lipid peroxidation at all concentrations.
This protective effect suggests that other possiblemechanisms
of action of the antioxidant activity are associated with
the ability of this extract to scavenge the hydroxyl (∙OH)
radical. Interestingly, PT (800mg/kg) also attenuated lipid
peroxidation when administered to mice. This protection
was similar to that observed for fluoxetine (32mg/kg) and
occurred at a dose that showed an antidepressant-like effect.
Fluoxetine decreased lipid peroxidation probably due to the





availability for the formation of the ∙OH radical. Similarly,
fluoxetine exerted a restorative action on the oxidative
effects in the peripheral defense cells of animals submitted
to the restraint stress model, which was also associated
with enhanced endogenous antioxidant defenses (CAT and
SOD) and the restoration of GSH levels [37]. Oxidative
damage to lipids and decreased antioxidant enzyme activ-
ity have been reported in patients with major depressive
disorder [38], and preclinical studies have suggested that
antioxidants may have antidepressant properties [39]. Taking
into account these findings, the inhibition of lipid perox-
idation by PT as well as the ability of PT to scavenge
free radicals strongly suggests a link between the antiox-
idant activity and the antidepressant-like effects observed
here.
The present study showed the in vitro and ex vivo antiox-
idant and antidepressant-like effects of PT in mice. These
antioxidant propertiesmight be related to the antidepressant-
like activity of Plinia trunciflora.

















































































Figure 5: Effects of PT (800mg/kg, p.o.) and fluoxetine (32mg/kg, i.p.) treatment on antioxidant enzyme activities SOD (a), GPx (b), TrxR














































Figure 6: Effects of PT (800mg/kg, p.o.) and fluoxetine (32mg/kg, i.p.) on lipid peroxidation (a) and nonprotein thiol groups (NPSH) level
(b). The results are expressed as the means ± S.E.M. 𝑛 = 6. ∗𝑝 < 0.05 × saline. ANOVA/Tukey.
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